Drug Approval

Zydus receives EIR for the injectable facility located at Jarod

This inspection was conducted following the warning letter issued by the USFDA

Zydus has received the Establishment Inspection Report (EIR) from the USFDA for a GMP follow-up inspection conducted at its injectable facility located at Jarod, Vadodara from August 25 to September 5, 2025 and classifying the facility as Voluntary Action Indicated (VAI).

This inspection was conducted following the warning letter issued on August 29, 2024 by the USFDA.

Zydus
USFDA

Upcoming E-conference

Other Related stories

GSK’s experimental lung cancer drug gains FDA orphan drug status

Bristol Myers Squibb scores FDA priority review for Opdivo in advanced hodgkin lymphoma

Apitoria Pharma receives 3 observations from USFDA for Unit-V

Interviews

Only 4-5 I

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 I

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Companies

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Appointments

Jubilant Pharmova appoints Daniel J. O Connor as CEO of Jubilant Therapeutics

Jubilant Pharmova appoints Daniel J. O Connor as CEO of Jubilant Therapeutics

Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence

Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence

Hester Biosciences appoints Ashish Desai as CFO

Hester Biosciences appoints Ashish Desai as CFO

Startup

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups

EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Digitization

Grace and Molecule.one strike multi-year AI pact to break peptide manufacturing bottlenecks

Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform

Avandra Health acquires DatCard and Sorna to build industry-leading medical imaging platform

L&T Technology unveils next-gen AI digital twin for lung diagnostics

L&T Technology unveils next-gen AI digital twin for lung diagnostics

Latest Stories

Lilly drug cuts risk of cancer progression, extends survival in advanced breast cancer trial

EMA backs higher-dose Wegovy, clearing path for greater weight loss option in Europe

EMA backs Eylea 8 mg for retinal vein occlusion

Merck wins key EU backing to expand use of PAH Drug WINREVAIR

UPM unveils world’s first carbon-negative, fully recyclable black pigment

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

From Policy to Practice: How India’s Pharmaceutical Industry is Being Shaped by the PLI Scheme – by Vikram Aditya Sehgal, Director – Finance, Centrient India

Interviews

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging

UPM unveils world’s first carbon-negative, fully recyclable black pigment

UPM unveils world’s first carbon-negative, fully recyclable black pigment

Aptar acquires Brazilian pharma packaging firm Sommaplast

Aptar acquires Brazilian pharma packaging firm Sommaplast

SOMA and Aura partner to advance innovation in on-press color correction

SOMA and Aura partner to advance innovation in on-press color correction